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Abstract
Purpose—This study examines whether ambivalence towards mammography screening, as
moderated by total amount of thought given to the reasons for and against getting mammograms at
recommended intervals, predicts greater delay in obtaining subsequent screening mammograms.
Methods—A sample of 3,430 insured women with recent (within the last 8–9 months) screening
mammograms completed telephone interviews as part of a five year intervention study to achieve
sustained adherence to annual-interval mammography. Delay was assessed by the number of days
between mammograms.
Results—Controlling for demographic factors and perceived screening barriers, days between
mammograms increased as ambivalence and thought increased. Thought moderated ambivalence:
among women who were most ambivalent, women obtained mammograms a month earlier for
each unit increase in thought.
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Conclusion—Future studies should test innovative ways to resolve ambivalence and increase
thought about consequences of getting mammograms as a strategy to promote mammography
screening adherence.
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In the U.S. last year, an estimated 192,370 women were diagnosed with breast cancer;
40,170 died from the disease (ACS, 2010). Along with advances in adjuvant care,
mammography screening remains an important means of reducing disease-related morbidity
and mortality (Jemal et al., 2010; Kalager et al., 2010). However, renewed controversies and
other issues may prompt some women, and possibly, some clinicians, to rethink the benefits
of mammography, resulting in ambivalence about getting screened at all as well as the
schedule on which women should be screened (USPSTF, 2009; Mandelblatt et al., 2009;
Partridge & Winer, 2009; Truog, 2009; Quanstrum & Hayward, 2010; Welch, 2010).
Ambivalence, defined as holding both positive and negative attitudes towards an object, in
this case, mammography (Cacioppo & Berntson, 1994; Jonas & Ziegler, 2007), may have
contributed to the slight downturn in mammography use in the U.S. (Centers for Disease
Control and Prevention, 2007; Miller et al., 2009). Indeed, greater screening-related
ambivalence is associated with lower rates of adherence to recent colon and breast cancer
screening (Lipkus & Klein, 2006; Halabi, Skinner, Samsa, Strigo, Crawford, & Rimer,
2000).
Feeling ambivalent can be uncomfortable (Clark et al., 2008). This discomfort may motivate
resolution of ambivalence (Newby-Clark, McGregor, & Zanna, 2002). Specifically, from a
stress and coping perspective (Lazarus, 1991; Lazarus & Folkman, 1984), the emotional
discomfort associated with ambivalence may serve as a cue to engage and cope with a
potentially stressful event (Larsen, Hemenover, Norris & Cacioppo, 2003; Haenze, 2001;
Lazarus, 1991; Luce, 1998; Luce, Payne & Bettman, 2001; Wenzel, Glanz, & Lerman,
2002; Jonas, Diehl, & Bromer, 1997; Maio, Esses, & Bell, 1996; van Harreveld et al., 2009).
To cope with ambivalence and related negative emotions, these women may distance
themselves from thinking about and having mammograms. Conversely, women may try to
resolve ambivalence by spending time thinking about reasons for and against getting
mammograms at recommended intervals as a means of problem-focused coping (Jonas,
Broemer, & Diehl, 2000). Women who raise more reasons for (rather than against) getting
their next mammograms on recommended schedules should be more likely to get screened.
These processes are consistent with findings which show that people with greater
ambivalence process messages more extensively, especially if these messages are perceived
by recipients to reduce ambivalence (Clark et al., 2008). Thinking about potential reasons
for and against getting mammograms on recommended schedules may be one way that
women resolve their mammography-related ambivalence.
We conducted a five year intervention study to achieve sustained adherence to annual-
interval mammography in a sample of 3,430 women that began as currently-adherent
(DeFrank et al., 2009; Gierisch et al., 2010a). We examined how ambivalence toward
mammography screening, moderated by the total amount of thought given to reasons for and
against getting mammograms at recommended intervals, influenced receipt of subsequent
screening mammograms among women with recent (within the last 8 to 9 months) screening
mammograms. Our research aim in the present study was to assess the impact of
ambivalence, total thought and interaction of ambivalence and thought on number of days
between two consecutive screening mammograms in a sample of insured women. As we
have done in previous reports (Gierisch et al., 2010a), we used days between mammograms
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as our outcome. This option is more sensitive to smaller variations in adherence than a
dichotomous outcome (Gierisch et al., 2010b). We tested three hypotheses.
H1 With increasing levels of ambivalence, women would spend more time thinking
about positive consequences of getting and negative consequences of not getting
their next screening mammograms.
H2 Greater levels of baseline ambivalence and total amount of thought given to
reasons for and against getting mammograms at recommended intervals would
predict greater delay in obtaining women’s next screening mammograms.
H3 Thought would moderate ambivalence, such that at increasing levels of
ambivalence, more time spent thinking about reasons for and against getting




Data for these analyses are from Personally Relevant Information about Screening
Mammography (PRISM) that took place from 2003 to 2008. Study eligibility and
recruitment are described elsewhere (DeFrank et al., 2009; Gierisch et al., 2009, 2010a).
Briefly, eligible women from the parent study were North Carolina residents enrolled with
the North Carolina State Health Plan for Teachers and State Employees (SHP) for two or
more years prior to sampling, had no personal history of breast cancer, and were between
ages of 40 and 75. To ensure uniform adherence to mammography upon study enrollment,
we invited women who had screening mammograms 8 to 9 months before study entry. We
enrolled 3,547 women into PRISM who completed baseline telephone interviews. All
measures reported here are baseline measures. For this report, we conducted analyses on
3,430 PRISM participants; 20 women were excluded, because they had their next
mammograms less than 10 months (304 days) after their previous mammograms. Thus,
these subsequent mammograms probably were not for routine screening. Fifty-two women
were excluded from these analyses, because there were too few women in groups other than
white and African American. An additional 45 women were excluded due to item
nonresponse on key predictor and outcome variables used for these analyses. As part of
PRISM, all participants received reminders two to three months prior to their mammography
due dates. See DeFrank et al. (2009) and Gierisch et al. (2010a) for background on
interventions. This study was approved by the Biomedical Institutional Review Boards of
[blinded by WHI editors].
Measures: Baseline Predictor Variables
Sociodemographics—We collected baseline data on age, race (1 = White, 0 = African
American), educational attainment (1 = college graduate/post graduate, 0 = some college/
technical school, high school graduate/not completing high school), and perceived financial
hardship (1 = money available after paying bills for special things, 0 = little or no spare
money available after paying bills; Williams et al., 1992).
Ambivalence about Mammography—We examined the role of felt rather than
potential for ambivalence. Whereas potential for ambivalence indexes the underlying degree
of inconsistency (conflict) between positive and negative beliefs, felt ambivalence captures
the actual experience of this conflict. Modeled after questions used previously in
mammography research (Halabi et al., 2000; Lipkus & Klein, 2006), ambivalence was
measured by agreement with two statements: 1) You have mixed feelings about whether you
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should get another mammogram when you are due; and 2) You are torn about whether you
should get a mammogram when you are due (4-point scale, Strongly disagree-strongly
agree). The items were correlated at .60 (p < .0001) and summed (range 2–8).
Amount of thought—Participants indicated how often during the last week they thought
about: 1) benefits you could gain from having a mammogram when you are due, and 2)
benefits you could lose if you did not have a mammogram when you are due. Response
options were: none of the time, a little of the time, a moderate amount of time, and most of
the time. These strongly correlated items (r = .79; p < .0001) were summed (range 2–8).
Perceived barriers to mammography—We assessed 10 closed-ended barriers to
mammography use (Champion, 1999; Champion & Skinner, 2003; Rimer et al., 1989). Each
participant was asked, “I am going to read you a list of reasons some women say have
delayed their getting mammograms. For each reason, please tell me if it could delay you
getting a mammogram when you are due.” Response options were strongly agree, somewhat
agree, somewhat disagree, strongly disagree. We considered barriers present if participants
endorsed somewhat or strongly agree for any barrier. Barriers then were summed.
Outcome Variable
Days between mammograms—Our outcome was the number of days between
mammograms. We counted the number of days between participants’ eligibility
mammograms, which occurred 8 to 9 months before study entry, and their next screening
mammograms. A calculated variable counted number of days until receipt of subsequent
mammograms; counting ceased when women received subsequent mammograms.
We assessed mammography screening through a combination of health insurance claims
data and self-report. If a discrepancy occurred, self-report dates were used, as claims data
can sometimes be incomplete due to lag time in claims processing, women’s paying out of
pocket or filing claims with alternate insurance (DeFrank et al., 2009; Gierisch et al.,
2010a). Previous research has shown that self-reports are a valid measure of recent
mammograms, especially for women in healthcare organizations and over short recall
periods (e.g., Rauscher, et al., 2008).
Data Analyses
After examining descriptive statistics, including variable distributions and the bivariate
correlation between ambivalence and thought, we used multivariable linear regression
(MLR) analysis using SAS PROC GLM to examine the impact of total thought,
ambivalence, and the interaction of thought and ambivalence on a count of elapsed days
between successive mammograms. We controlled for sociodemographics (race, age,
education, and income), total number of self-reported barriers to obtaining mammograms,
and PRISM intervention arms in regression analyses. We probed interaction effects between




Most women were white, aged ≥ 50, college educated, married or living as married and did
not report financial hardship (Table 1). On average, participants did not spend much time
thinking about the positive and negative consequences of getting/not getting their next
mammograms when due. Most women were not very ambivalent about mammography
(mean = 2.2, range = 2–8) and reported few barriers (mean =0.7; range = 0–10).
O’Neill et al. Page 4













Multivariable Model Predicting Days Between Mammograms
Table 2 presents MLR regression coefficients and standard errors examining the relationship
between total thought, ambivalence, and the interaction of thought and ambivalence,
controlling on socio-demographics, arm of the study, and barriers. Although ambivalence
was unrelated to total thought (r = −.02, p = 0.35), we found support for our other
hypotheses. Specifically, main effects of both ambivalence and thought were positive. The
interaction was negative, indicating an attenuating effect of thought with increasing values
of ambivalence.
Probing of MLR 2-Way Interaction
To further assess this interaction effect, we plotted the simple slopes and intercepts to
examine the impact of thought at three values of ambivalence (2, 4, and 6) (See Figure 1).
The lower bound of the region of significance is −1.2, below the minimal value of the
distribution of thought. The upper bound of the region of significance is 2.3, well within the
distribution of total thought (range 2–8). With increasing levels of ambivalence, increased
thought was related to fewer days between mammograms. For example, women obtained
mammograms one-half month (15.7 days) earlier for each unit increase in total thought at an
ambivalence level of 4 (t = −2.40, p < .05). Women received mammograms a month (29.9
days) earlier for each unit of thought change at an ambivalence level of 6 (t = −2.3, p < .05).
Discussion
Prior studies have shown that people who feel ambivalent about cancer screening are less
likely to be screened (Halabi et al., 2000; Lipkus & Klein, 2006). This study replicates this
pattern of findings for obtaining consecutive screening mammograms. These findings extend
prior research by including examination of an effect modifier, amount of thought devoted to
considering positive and negative consequences of getting/not getting women’s next
mammograms on schedule. Among women who were most ambivalent about getting their
next mammograms on schedule, those who thought more about the consequences had
significantly fewer days between consecutive screening mammograms—a full month fewer
—compared to those who considered consequences less often. This effect was significant
even after controlling for demographic factors and barriers, known contributors to screening
delay (O’Malley et al., 2002; Champion, 1994; Maxwell & Bradford, 1996; Partin & Slater,
2003; Blanchard et al., 2004; Rakowski et al., 2004; Bobo et al., 2004). While the clinical
impact on personal and population health of a one month delay in screening mammography
is unknown, cumulative delays over the course of an individual woman’s lifetime or in the
population as a whole may impact disease-related morbidity and mortality (Mandelblatt et
al., 2009; Partridge & Winer, 2009). This is true whether the screening schedule is annual or
biennial mammography.
Ambivalence may contribute to the recent downturn in mammography use nationally
(Centers for Disease Control and Prevention, 2007). Women who feel more ambivalent
about screening may represent an important, reachable target group for mammography
screening intervention efforts. Indeed, the main effect for ambivalence was quite strong.
Notably, given that at baseline women in our sample were adherent to mammography, it is
not surprising that most had low levels of ambivalence. Ambivalence may be an even more
important factor for non-adherent women and for other screening and treatment choices
(colorectal cancer screening, prenatal screening, prostate cancer treatment), in which people
may feel greater ambivalence (Sapp et al. 2010; Bungay & Cappello, 2009; Lipkus et al.,
2003). We might expect that there would be greater ambivalence about screening tests that
are not as well-diffused across populations as mammography.
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While we are aware of no interventions that incorporate strategies to reduce ambivalence
and increase deliberative thought, having (highly) ambivalent women reflect upon their
reasons for getting mammograms shares many similarities to interventions designed to
promote mammography adherence. These include interventions that encourage women to
consider the pros and cons of mammography, both with and without clinician support
(Champion et al., 2003, 2006; Lauver et al., 2003; Rakowski et al., 2003; Russel et al., 2010;
Vernon et al., 2008), as well as Motivational Interviewing (Costanza et al., 2009) and
decision aid interventions (O’Connor, Stacey, Entwistle, Llewellyn-Thomas, Rovner,
Holmes-Rovner et al., 2003). Decision aids are most beneficial for patients who experience
decisional conflict. Their effects may be the result of patients becoming actively engaged in
such processes as value clarification and weighing of decisional pros and cons (O’Connor,
Fiset, DeGrasse, Graham, Evans, Stacey et al., 1999). Engaging people to think of reasons to
perform recommended behaviors may be of greatest benefit to those who are most
ambivalent or have the greatest decisional conflict (Schwartz et al., 2009). Indeed,
ambivalence shares commonalities with constructs such as decisional balance (Prochaska &
DiClemente, 1983; Rakowski et al., 1997) and decisional conflict (O’Connor et al., 1999,
2003).
This study has limitations. First, we did not manipulate ambivalence experimentally; no
causal relationships can be inferred. Indeed, it might be ethically inappropriate to induce
ambivalence in this context. Second, we used a rather crude measure of thought because we
were constrained by the number of questions we could ask. Whether a more sophisticated
measure would have yielded different results should be examined. Nonetheless, we found
support for our thought measures. Women who reported thinking more about the
consequences of getting/not getting their next mammograms on schedule generated more
open-ended responses when asked about these consequences. Third, we assessed only
thinking about the benefits gained by getting mammograms and the benefits lost by not
getting mammograms; such thoughts facilitate reasons for engaging in screening. We did not
assess amount of thought and content related to perceived negative consequences of getting
mammograms and perceived benefits gained by not undergoing screening as well.
Finally, our sample has limitations. PRISM’s design required all women to have health
insurance coverage and recent mammograms prior to study entry. Our purpose was to
improve sustained adherence, as part of the NIH Health Maintenance Consortium (Ory et
al., 2010). Our results cannot be generalized outside of these groups. Overall, women were
well-educated, and representation of black women and other racial and ethnic minorities in
the parent study was modest. This may have been a function of eligibility criteria but cannot
be confirmed (DeFrank et al., 2007). Further examination of these constructs in more
diverse samples is needed.
Despite these limitations, our study adds to a small, growing body of research about the
relationship between ambivalence and health behaviors, specifically, mammography. Our
results suggest that women who are ambivalent about mammography may be an important
target group for intervention. While even for mammography, ambivalence may be highly
skewed, ambivalence may be very important for those women who are ambivalent about the
screening procedure. Strategies that facilitate thinking about the consequences of
mammography should be considered; explicit tests of such interventions would be needed.
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Figure 1. Interaction Effects of Ambivalence and Total Thought on Days Between Mammograms
(n=3430)
Note. All analyses controlled for arm of research study, education, race, family finances,
age, educational attainment and number of self-reported barriers to obtaining mammograms.
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Table 1
Sample Characteristics (n=3,430)
Variable % M (SD)
Age 54.7 (6.3)
Race
    White 89.6
    Black 10.4
Education
    Less than college 37.2
    College graduate 62.8
Perceived financial hardship
    After paying bills, has money for special things 63.8
    Has money to pay bills, but little spare money 28.9
    Has money to pay bills due to cutback on things 5.3
    Has difficulty paying bills no matter what 2.0
Intervention categories
      Usual Care Reminder 24.0
      Enhanced Letter Reminder
      + BarriCon Call(+) 9.4
      Enhanced Letter Reminder
      + BarriCall 9.0
      Enhanced Letter Reminder
      + BarriCon Call(−) 9.7
      Enhanced Letter Reminder
      + Control Group 9.8
      Automated Telephone Reminder
      + BarriCon Call(+) 9.6
      Automated Telephone Reminder
      + BarriCall 9.9
      Automated Telephone Reminder
      + BarriCon Call(−) 9.4
      Automated Telephone Reminder
      + Control Group 9.2
Felt ambivalence 2.2 (0.8)
Total thought (benefits gained and lost) 3.0 (1.6)
Total perceived barriers to screening 0.7 (0.8)
Days from baseline to 12 month mammogram 442.6 (162.2)
Percent Adherent (305–425 days between successive mammograms) 74.9
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Table 2
Multivariable OLS Regression Predicting Interval in Days between Baseline and 12 Month Mammograms
(n=3430)
Variable Coefficient (SE) t-value
Intercept 558.9 (32.9) ---
Total thought 13.3 (5.5) 2.4*
Felt ambivalence 45.8 (8.0) 5.8***
Interaction between thought and ambivalence −7.2 (2.4) −3.0**
Total perceived barriers to screening 21.7 (3.6) 6.0***
Age −2.8 (0.44) −6.7***
Education
      Less than college Referent
      College graduate −11.0 (5.8) −1.89
Financial situation
      Greater financial hardship Referent
      After paying bills, enough money for special things −30.0 (5.9) −5.1***
Race
      Black Referent
      White −27.4 (5.9) −3.1**







Womens Health Issues. Author manuscript; available in PMC 2013 March 1.
